People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Artelon, Inc. | — | Biotechnology | Series B | $20.0M | $230.5M | 2023 |
Steve Becker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steve Becker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carter Meyer | 1 | 14 |
| Kirk Nielsen | 1 | 13 |
| MARK COHEN | 1 | 5 |
| Gary Burbach | 1 | 3 |
| Aaron Smith | 1 | 3 |
| Greg Banker | 1 | 1 |
| Jeff Byrne | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.